FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(080064259)" | Racepinephrine Hydrochloride; Tetracaine Hydrochloride; Lidocaine Hydrochloride | 1.5 mg/3 mL; 15 mg/3 mL; 120 mg/3 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Racepinephrine Hydrochloride; Tetracaine Hydrochloride; Lidocaine Hydrochloride | .75 mg/1.5 mL; 7.5 mg/1.5 mL; 60 mg/1.5 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride | 6 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride | 100 g/2000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride | 6 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 6000 mg/3000 mL; 6 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ropivacaine Hydrochloride; Fentanyl Citrate | 3000 mg/3000 mL; 6 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride; Fentanyl Citrate | 3000 mg/3000 mL; 6 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride; Fentanyl Citrate | 3750 mg/3000 mL; 6 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride; Fentanyl Citrate | 1875 mg/3000 mL; 6 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Bupivacaine Hydrochloride; Fentanyl Citrate | 5001 mg/3000 mL; 6 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ephedrine Sulfate | 30 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ephedrine Sulfate | 15 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ephedrine Sulfate | 30 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ephedrine Sulfate | 15 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Epinephrine | 30 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 60 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 150 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 150 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 1000 mg/2000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 250 mg/500 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 30 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Fentanyl Citrate | 30 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 3000 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 600 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 1500 mg/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 25 g/500 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 75 g/1500 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Labetalol Hydrochloride | 10 g/2000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "QuVa Pharma, Inc.(080064259)" | Lidocaine Hydrochloride | 27.3 g/3000 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Methylcobalamin | 5 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Neomycin Sulfate; Polymyxin B Sulfate; Dexamethasone | 3.5 mg/1 g; 10000 U/1 g; 1 mg/1 g | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Nitroglycerin | .0625 g/1 g | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | .2 g/1 g; .06 g/1 g; .04 g/1 g | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | .2 g/1 g; .06 g/1 g; .04 g/1 g | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Benzocaine; Lidocaine Hydrochloride; Tetracaine Hydrochloride | .12 g/1 g; .04 g/1 g; .08 g/1 g | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Betamethasone Acetate; Betamethasone Sodium Phosphate | 3 mg/1 mL; 3 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Podophyllum Resin; Cantharidin; Salicylic Acid | 50 mg/1 mL; 10 mg/1 mL; 300 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Procaine Hydrochloride | 20 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Bevacizumab | 1.25 mg/.05 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Ranibizumab | .5 mg/.05 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Squaric Acid Dibutyl Ester | 20 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Brolucizumab | 6 mg/.05 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Brolucizumab | 6 mg/.05 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Tetracaine Hydrochloride | 40 mg/1 mL | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Tetracaine Hydrochloride; Epinephrine Bitartrate; Lidocaine Hydrochloride | 5 mg/1 g; .5 mg/1 g; .04 g/1 g | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Tetracaine Hydrochloride; Epinephrine Bitartrate; Lidocaine Hydrochloride | 5 mg/1 g; .5 mg/1 g; .04 g/1 g | 2020-1 | source_no_ndc | 2026-11-12 | ||||
| "RAM Pharma, Inc.(079866136)" | Vancomycin Hydrochloride | 1000 ug/.1 mL | 2020-1 | source_no_ndc | 2026-11-12 |